AMBALALSA.NS

Ambalal Sarabhai Enterprises Limited

NSEHealthcare

₹32.71

▲ +2.51%+₹0.80 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹31.91

Day range

₹0 – ₹0

52W range

₹30.3 – ₹38.5

Volume

52.8K

Avg vol (20D)

75.2K

Mkt cap

₹251.51Cr

P/E TTM

14.1×

Trade Ambalal Sarabhai Enterprises Limited with Artha

Company Metrics

Revenue (ttm)₹202.27 Cr

Net Income (ttm)₹0.00

Shares Out0.00

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta-0.01

About AMBALALSA.NS

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolAMBALALSA.NS

Websitehttps://www.ase.life

AMBALALSA.NS · NSE

Financial Performance

In 2026, Ambalal Sarabhai Enterprises Limited's revenue was ₹202.27 Cr, an decrease of +0.70% compared to the previous year. Earnings were ₹0.00, an decrease of 0.00%.

Revenue (2026)

₹202.27 Cr

↘-0.70% YoY

Earnings (2026)

₹0.00

→0.00% YoY

Year-over-Year Growth

Revenue

-0.70%

Earnings

0.00%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account